Patent · US Active

Anti-tumor drug, medicament, composition, and use thereof

US7906621B2 · kind B2 · utility

0Cited by

2References

13Claims

0Family size

Assignee

GENE SIGNAL INTERNATIONAL SA · CH

Inventors

Sylvie Colin · Paris, FR
Salman Al-Mahmood · Paris, FR

Key dates

Filing date	May 16, 2007
Grant date	Mar 15, 2011
Priority date	—
Expiry date	Sep 7, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An active polypeptide includes the amino acid sequence of SEQ ID NO:3, or having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of SEQ ID NO:3, or fragments thereof having at least 20 contiguous amino acids, or peptides having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of the fragments, provided that the polypeptide is not SEQ ID NO:2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.